ArticleJournal for immunotherapy of cancer2021

HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.

Ana Marcu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.